Searching for invulnerability to cancer

In June 2013, I described how sequencing the highly abnormal genomes of cancer cells can identify some of the mutations that drive the progress of the disease (and how that’s only the beginning of the story). In the discussion that ensued, reader BlueSky3 commented:

Hope more likely rests in examining the control systems/defence mechanisms of those carrying a hereditary cancer fault which has perhaps persisted in evolutionary time. Not all mutation carriers succumb. Why not?

This comment was so interesting that it’s been percolating at the back of my brain for months. We know that smokers have a highly elevated risk of developing lung, throat, or oral cancer – but some of them don’t. Why?

Read the full, original story: Unbreakable: do superheroes, impervious to cancer, walk among us?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
a ufo a photoblog
U.S. government accused of pushing ‘fake news’ about UFOs to cover-up secret dark-project drone and aircraft technology
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.